All in one respiratory screening through the Tambua App + T-Scope 1000
Over 2 Million people die each year because of Pneumonia, Asthma, COPD, and Pulmonary TB. Although these diseases have a cure or are preventable, early diagnosis is crucial in the treatment of these diseases. WHO case management algorithm for respiratory diseases relies solely on symptoms of shortness of breath or cough and tachypnoea for treatment and has poor diagnostic specificity, tends to increase antibiotic resistance. Alternatives, including oxygen saturation measurement, chest ultrasound, chest auscultation, and GeneXprt tests which are very expensive, inaccessible and have low accuracy.
Lung sounds are of significance as they provide valuable information on the health of the respiratory system. The Tambua App uses patient's, Lung auscultations, symptoms, risk factors and historical clinical information to screen for Pneumonia, Asthma, COPD and Pulmonary Tuberculosis in Adults and children. The Tambua App has a sensitivity value of 0.861, a specificity value of 0.825 and a total performance of 84.28%.